Zimmer Biomet (ZBH) Is Up 6.1% After Earnings Beat And New Buyback Plan Is Announced [Yahoo! Finance]
Zimmer Biomet (NYSE:ZBH) had its price target raised by analysts at Citigroup Inc. from $94.00 to $98.00. They now have a "neutral" rating on the stock.
Zimmer Biomet (NYSE:ZBH) had its price target raised by analysts at Wells Fargo & Company from $93.00 to $98.00. They now have an "equal weight" rating on the stock.
Zimmer Biomet (NYSE:ZBH) had its "sell" rating reaffirmed by analysts at UBS Group AG.
Zimmer Biomet (NYSE:ZBH) had its "buy" rating reaffirmed by analysts at Citigroup Inc..